Ilumetri 200 mg solution for injection in pre-filled syringe clinical trials

Evaluation of Tildrakizumab in the Treatment of Ocular Sequelae in Lyell syndrome

This study is looking at a new medicine called Ilumetri (tildrakizumab) for eye problems caused by Lyell syndrome. It aims to see if the medicine can help improve how long tears stay on the eye and make patients feel better about their eye symptoms and vision.